Early analysis of a potential link between viral load and the N501Y mutation in the SARS-COV-2 spike protein
Open accessAbstract
A new variant of SARS-CoV-2 has emerged which is increasing in frequency, primarily in the South East of England (lineage B.1.1.7 ( 1 ); VUI-202012/01). One potential hypothesis is that infection with the new variant results in higher viral loads, which in turn may make the virus more transmissible. We found higher (sequence derived) viral loads in samples from individuals infected with the new variant with median inferred viral loads were three-fold higher in individuals with the new variant. Most of the new variants were sampled in Kent and Greater London. We observed higher viral loads in Kent compared to Greater London for both the new variant and other circulating lineages. Outside Greater London, the variant has higher viral loads, whereas within Greater London, the new variant does not have significantly higher viral loads compared to other circulating lineages. Higher variant viral loads outside Greater London could be due to demographic effects, such as a faster variant growth rate compared to other lineages or concentration in particular age-groups. However, our analysis does not exclude a causal link between infection with the new variant and higher viral loads. This is a preliminary analysis and further work is needed to investigate any potential causal link between infection with this new variant and higher viral loads, and whether this results in higher transmissibility, severity of infection, or affects relative rates of symptomatic and asymptomatic infection Document Description and Purpose: This is an updated report submitted to NERVTAG in December 2020 as part of urgent investigations into the new variant of SARS-COV-2 (VUI-202012/01). It makes full use of (and is restricted to) all sequence data and associated metadata available to us at the time this original report was submitted and remains provisional. Under normal circumstances more genomes and metadata would be obtained and included before making this report public. We will update this preprint when more genomes and metadata are available and before submitting for peer review.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The Alpha variant was associated with threefold to eightfold higher upper-airway levels.
“It was also associated with threefold to eightfold higher upper-airway levels [199][200][201]”
From The biological and clinical significance of emerging SARS-CoV-2 variants (2021) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Part of this paper’s reference list could not be split into single entries.
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,242 · see citing works
Prevalence of Asymptomatic SARS-CoV-2 Infection
Oran, D. P., & Topol, E. J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3012 · Cited by 2,280 · see citing works
Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70
Kemp, S. A., Meng, B., Ferriera, I. A., Datir, R., Harvey, W. T., Papa, G., Lytras, S., Collier, D. A., Mohamed, A., Gallo, G., et al. (2020) · doi:10.1101/2020.12.14.422555 · Cited by 252 · see citing works
Kissler, S. M., Fauver, J. R., Mack, C. D., Olesen, S. W., Tai, C. G.-L., Shiue, K. Y., Kalinich, C. C., Jednak, S., Ott, I. M., Vogels, C. B. F., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001333 · Cited by 251 · see citing works
Virulence and Pathogenesis of HIV-1 Infection: An Evolutionary Perspective
Fraser, C., Lythgoe, K., Leventhal, G. E., Shirreff, G., Hollingsworth, T. D., Alizon, S., & Bonhoeffer, S. (2014) · Science · doi:10.1126/science.1243727 · Cited by 243 · see citing works
Self-citationEstimating epidemiologic dynamics from cross-sectional viral load distributions
Hay, J. A., Kennedy-Shaffer, L., Kanjilal, S., Lennon, N., Gabriel, S., Lipsitch, M., & Mina, M. (2020) · Science · doi:10.1126/science.abh0635 · Cited by 242 · see citing works
Viral dynamics of acute SARS-CoV-2 infectionPreprint
Kissler, S. M., Fauver, J. R., Mack, C. D., et al. (2020) · medRxiv · doi:10.1101/2020.10.21.20217042 · Cited by 94 · see citing works
Bonsall, D., Golubchik, T., de Cesare, M., Limbada, M., Kosloff, B. R., MacIntyre-Cockett, G., Hall, M. D., Wymant, C., Ansari, M. A., Abeler‐Dörner, L., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00382-20 · Cited by 78 · see citing works
Self-citationEstimating epidemiologic dynamics from cross-sectional viral load distributionsPreprint
Hay, J. A., Kennedy‐Shaffer, L., Kanjilal, S., et al. (2020) · medRxiv · doi:10.1101/2020.10.08.20204222 · Cited by 66 · see citing works
Walker, A. S., Pritchard, E., House, T., Robotham, J. V., Birrell, P., Bell, I., Bell, J. I., Newton, J. N., Farrar, J., Diamond, I. D., et al. (2020) · medRxiv · doi:10.1101/2020.10.25.20219048 · Cited by 31 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- A. Sarah Walker, E. Pritchard, T. House, J. V. Robotham, P. J. Birrell, I. Bell, J. I. Bell, J. N. Newton, J. Farrar, I. Diamond, R. Studley, J. Hay, K.-D. Vihta, T. Peto, N. Stoesser, P. C. Matthews, D. W. Eyre, K. B. Pouwels, the COVID-19 Infection Survey team, Viral load in community SARS-CoV-2 cases varies widely and temporally. medRxiv , 2020.10.25.20219048 (2020).
- S. M. Kissler, J. R. Fauver, C. Mack, S. W. Olesen, C. Tai, K. Y. Shiue, C. C. Kalinich, S. Jednak, I. M. Ott, C. B. F. Vogels, J. Wohlgemuth, J. Weisberger, J. DiFiori, D. J. Anderson, J. Mancell, D. D. Ho, N. D. Grubaugh, Y. H. Grad, SARS-CoV-2 viral dynamics in acute infections. medRxiv , 2020.10.21.20217042 (2020).
Cited by
Sorted by citations
The biological and clinical significance of emerging SARS-CoV-2 variants
Tao, K., Tzou, P. L., Nouhin, J., Gupta, R. K., de Oliveira, T., Kosakovsky Pond, S. L., Fera, D., & Shafer, R. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00408-x · Cited by 1,009 · see citing works
Estimating infectiousness throughout SARS-CoV-2 infection course
Jones, T. C., Biele, G., Mühlemann, B., Veith, T., Schneider, J. A., Beheim-Schwarzbach, J., Bleicker, T., Tesch, J., Schmidt, M. L., Sander, L. E., et al. (2021) · Science · doi:10.1126/science.abi5273 · Cited by 716 · see citing works
Emary, K. R. W., Golubchik, T., Aley, P. K., Ariani, C. V., Angus, B., Bibi, S., Blane, B., Bonsall, D., Cicconi, P., Charlton, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00628-0 · Cited by 603 · see citing works
Self-citationFrampton, D., Rampling, T., Cross, A., Bailey, H., Heaney, J., Byott, M., Scott, R., Sconza, R., Price, J., Margaritis, M., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00170-5 · Cited by 387 · see citing works
Najjar, D., Rainbow, J., Sanjay, S. T., Jolly, P., de Puig, H., Yafia, M., Durr, N., Sallum, H. M., Alter, G., Li, J. Z., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00919-w · Cited by 292 · see citing works
Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
Gómez, C. E., Perdiguero, B., & Estéban, M. (2021) · Vaccines · doi:10.3390/vaccines9030243 · Cited by 262 · see citing works
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Ramesh, S., Govindarajulu, M., Parise, R. S., Neel, L. T., Shankar, T., Patel, S., Lowery, P., Smith, F., Dhanasekaran, M., & Moore, T. (2021) · Vaccines · doi:10.3390/vaccines9101195 · Cited by 152 · see citing works
SARS-CoV-2 one year on: evidence for ongoing viral adaptation
Peacock, T. P., Penrice-Randal, R., Hiscox, J. A., & Barclay, W. (2021) · Journal of General Virology · doi:10.1099/jgv.0.001584 · Cited by 149 · see citing works
Quantifying the relationship between SARS-CoV-2 viral load and infectiousness
Marc, A., Kerioui, M., Blanquart, F., Bertrand, J., Mitjà, J., Corbacho‐Monné, M., Marks, M., & Guedj, J. (2021) · eLife · doi:10.7554/elife.69302 · Cited by 146 · see citing works
The global epidemic of SARS‐CoV‐2 variants and their mutational immune escape
Tian, D., Sun, Y., Zhou, J., & Ye, Q. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27376 · Cited by 101 · see citing works
Brown, J. C., Goldhill, D. H., Zhou, J., Peacock, T. P., Frise, R., Goonawardane, N., Baillon, L., Kugathasan, R., Pinto, A., McKay, P. F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.24.432576 · Cited by 68 · see citing works
Binnicker, M. J. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00469-21 · Cited by 68 · see citing works
Banada, P. P., Green, R., Banik, S., Chopoorian, A., Streck, D. L., Jones, R., Chakravorty, S., & Alland, D. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00845-21 · Cited by 61 · see citing works
Dwivedi, R., Samanta, P., Sharma, P., Zhang, F., Mishra, S. K., Kucheryavy, P., Kim, S. B., Aderibigbe, A. O., Linhardt, R. J., Tandon, R., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101207 · Cited by 49 · see citing works
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Hoteit, R., & Yassine, H. M. (2022) · Vaccines · doi:10.3390/vaccines10060919 · Cited by 45 · see citing works
Zimerman, R. A., Ferrareze, P. A. G., Cadegiani, F., Wambier, C. G., Fonseca, D. D. N., de Souza, A. R., Goren, A., Rotta, L. N., Ren, Z., & Thompson, C. E. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.806611 · Cited by 32 · see citing works
Olsen, R. J., Christensen, P. A., Long, S. W., Subedi, S., Hodjat, P., Olson, R., Nguyen, M., Davis, J. J., Yerramilli, P., Saavedra, M. O., et al. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.07.002 · Cited by 30 · see citing works
Altered Subgenomic RNA Expression in SARS-CoV-2 B.1.1.7 InfectionsPreprint
Parker, M. D., Lindsey, B., Shah, D. R., Hsu, S., Keeley, A., Partridge, D., Leary, S., Cope, A., State, A., Johnson, K., et al. (2021) · bioRxiv · doi:10.1101/2021.03.02.433156 · Cited by 33 · see citing works
Meyer, M., Holfter, A., Ruebsteck, E., Gruell, H., Dewald, F., Koerner, R. W., Klein, F., Lehmann, C., Huenseler, C., & Weber, L. T. (2021) · Viruses · doi:10.3390/v13081600 · Cited by 26 · see citing works
Surveillance of SARS-CoV-2 lineage B.1.1.7 in Slovakia using a novel, multiplexed RT-qPCR assay
Boršová, K., Paul, E. D., Kováčová, V., Radvánszka, M., Hajdu, R., Čabanová, V., Slavíková, M., Ličková, M., Lukáčiková, Ľ., Belák, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99661-7 · Cited by 27 · see citing works
Lythgoe, K., Golubchik, T., Hall, M. D., House, T., Cahuantzi, R., MacIntyre-Cockett, G., Fryer, H. R., Thomson, L., Nurtay, A., Ghafari, M., et al. (2023) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2023.1284 · Cited by 28 · see citing works
Self-citationStorti, B., Quaranta, P., Primio, C. D., Clementi, N., Mancini, N., Criscuolo, E., Spezia, P. G., Carnicelli, V., Lottini, G., Paolini, E., et al. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.10.038 · Cited by 20 · see citing works
Parker, M. D., Stewart, H., Shehata, O. M., Lindsey, B. B., Shah, D. R., Hsu, S. N., Keeley, A. J., Partridge, D. G., Leary, S., Cope, A., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03565-9 · Cited by 49 · see citing works
Shrestha, L., Lin, M. J., Xie, H. J., Mills, M. G., Bakhash, S. A. M., Gaur, V. P., Livingston, R. J., Castor, J., Bruce, E. A., Botten, J., et al. (2022) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2022.05.007 · Cited by 17 · see citing works
Transmission characteristics of SARS-CoV-2 variants of concern Rapid Scoping ReviewPreprint
Curran, J., Dol, J., Boulos, L., Somerville, M., McCulloch, H., Macdonald, M., LeBlanc, J. J., Barrett, L. L., Hatchette, T. F., Comeau, J. L., et al. (2021) · medRxiv · doi:10.1101/2021.04.23.21255515 · Cited by 15 · see citing works
Cadegiani, F., Fonseca, D. D. N., McCoy, J. M., Zimerman, R. A., Mirza, F. N., Correia, M. D. N., Barros, R. N., Onety, D. C., Israel, K. C. P., de Almeida, B. G., et al. (2021) · medRxiv · doi:10.1101/2021.06.22.21259318 · Cited by 12 · see citing works
Eales, O. D., Page, A. J., Tang, S. N., Walters, C. E., Wang, H., Haw, D., Trotter, A. J., Le-Viet, T., Foster-Nyarko, E., Prosolek, S. J., et al. (2021) · medRxiv · doi:10.1101/2021.05.08.21256867 · Cited by 11 · see citing works
Lockdowns exert selection pressure on overdispersion of SARS-CoV-2 variants
Nielsen, B. F., Eilersen, A., Simonsen, L., & Sneppen, K. (2022) · Epidemics · doi:10.1016/j.epidem.2022.100613 · Cited by 10 · see citing works
Fryer, H. R., Golubchik, T., Hall, M. D., Fraser, C., Hinch, R., Luca Ferretti, A., Thomson, L., Nurtay, A., Pellis, L., House, T., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011461 · Cited by 9 · see citing works
Self-citationLythgoe, K., Golubchik, T., Hall, M. D., House, T., Cahuantzi, R., MacIntyre-Cockett, G., Fryer, H. R., Thomson, L., Nurtay, A., Ghafani, M., et al. (2022) · medRxiv · doi:10.1101/2022.01.05.21268323 · Cited by 9 · see citing works
Self-citationJumping a Moving Train: SARS-CoV-2 Evolution in Real Time
Moustafa, A. M., & Planet, P. J. (2021) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piab051 · Cited by 8 · see citing works
Surveillance of SARS-CoV-2 lineage B.1.1.7 in Slovakia using a novel, multiplexed RT-qPCR assayPreprint
Kováčová, V., Boršová, K., Paul, E. D., Radvánszka, M., Hajdu, R., Čabanová, V., Slavíková, M., Ličková, M., Lukáčiková, Ľ., Belák, A., et al. (2021) · medRxiv · doi:10.1101/2021.02.09.21251168 · Cited by 8 · see citing works
Viral loads observed under competing strain dynamicsPreprint
Hay, J. A., Kennedy‐Shaffer, L., & Mina, M. J. (2021) · medRxiv · doi:10.1101/2021.07.27.21261224 · Cited by 8 · see citing works
Banada, P. P., Green, R., Streck, D. L., Kurvathi, R., Reiss, R., Banik, S., Daivaa, N., Montalvan, I., Jones, R., Marras, S. A. E., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-48647-8 · Cited by 7 · see citing works
Up-to-date nucleic acid assays for diagnosing respiratory infection
Yatera, K., Nishida, C., & Mukae, H. (2025) · Respiratory Investigation · doi:10.1016/j.resinv.2025.03.004 · Cited by 5 · see citing works
Çubuk, H., & Özbil, M. (2022) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2022.108260 · Cited by 5 · see citing works
SARS-CoV-2 variants of concern: the knowns and unknowns
Lessells, R. J. (2021) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2021.100868 · Cited by 5 · see citing works
МОЛЕКУЛЯРНО-ЕПІДЕМІОЛОГІЧНІ АСПЕКТИ SARS-COV-2
Задорожна, В. І. (2021) · Інфекційні хвороби · doi:10.11603/1681-2727.2021.1.11949 · Cited by 3 · see citing works
Fryer, H. R., Golubchik, T., Hall, M. D., Fraser, C., Hinch, R., Luca Ferretti, A., Thomson, L., Nurtay, A., Pellis, L., MacIntyre-Cockett, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.02.518847 · Cited by 3 · see citing works
Self-citationHill, K., Dewar, R., & Templeton, K. E. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab303 · Cited by 2 · see citing works
y Castro, T. R., Piccoli, B. C., Vieira, A. D. A., Casarin, B. C., Tessele, L. F., Salvato, R. S., Gregianini, T. S., Martins, L. G., Resende, P. C., Pereira, E. C., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11122938 · Cited by 1 · see citing works
Genomics and epidemiology of SARS-CoV-2 lineage
Sukegawa, S., & Takeuchi, H. (2021) · Uirusu · doi:10.2222/jsv.71.19 · Cited by 1 · see citing works
Couzens, A., Murrell, I., Gifford, L., Johns, B., Pheasant, K., Turner, L., Evans, J., & Moore, C. (2021) · medRxiv · doi:10.1101/2021.04.02.21254832
Efficacy of Proxalutamide (GT0918) in Hospitalized COVID-19 PatientsPreprint
Cadegiani, F., Fonseca, D. D. N., McCoy, J. M., Zimerman, R. A., Mirza, F. N., Correia, M. D. N., Barros, R. N., Onety, D. C., Israel, K. C. P., de Almeida, B. G., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3866539
HIGHLIGHTS OF COVID VACCINE ERA'S IN LOW ASSETNATIONS.
Patel, B., Golani, P., Nagdev, S. A., Jaisinghani, H., & Mishra, R. (2021) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/2726571
- Authors
- Golubchik, T., Lythgoe, K. A., Hall, M., Ferretti, L., Fryer, H. R., MacIntyre-Cockett, G., de Cesare, M., Trebes, A., Piazza, P., Buck, D., Todd, J. A., The COVID-19 Genomics UK (COG-UK) consortium, Fraser, C., & Bonsall, D.
- Affiliations
- University of Oxford (GB)
- Centre for Human Genetics (GB)
- Corresponding author
- Golubchik, Tanya
- Bonsall, David
- ORCID
- Venue
- medRxiv
- Publisher
- openRxiv
- Published
- 2021-01-15
- OpenAlex
- W3125312786
- Cited by
- 45
- References
- 8
- Citations by year
- 2025: 1 · 2023: 4 · 2022: 9 · 2021: 31
- Type
- posted content
- Language
- en
- Open access
- green
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- medRxiv (acceptedVersion, cc-by-nc-nd)
- Funders
- Wellcome Trust (203141/Z/16/Z, 203141, 107652/Z/15/Z)
- UK Research and Innovation
- National Institute for Health and Care Research (203141/Z/16/Z.)
- Medical Research Council (203141/Z/16/Z, COVID-19)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, viral load, N501Y mutation, spike protein, B.1.1.7 variant, viral transmissibility, viral genome sequence, Greater London, Kent
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
